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ABSTRACT

IN-HOUSE FABRICATION OF MULTI-SIZED POLYSTYRENE MICROCARRIERS
FOR NEURAL STEM CELL EXPANSION
By: Jessica Forrester, B.S.
A thesis submitted in partial fulfillment for the degree of Master of Science at Virginia
Commonwealth University.
Virginia Commonwealth University, 2016
Major Director: Ning Zhang, Ph.D.
Biomedical Engineering

The clinical demand for neural stem cells drives the need for a reproducible method used
to generate a large quantity of well-characterized cells to support regenerative therapies.
Microcarriers are currently being used as a scaffold for stem cell culture to aid in this
expansion process because they provide a larger surface area while also requiring fewer
cell passages compared to monolayer culture. The main objective of this project was to
investigate how human neural stem cell attachment, proliferation, and multipotency
would respond to three-dimensional (3D) culture using peptide-coated microcarriers of
varying diameters. In this study, multi-sized polystyrene microcarriers were fabricated

using a vibration generator and solvent evaporation techniques in order to optimize the
size distribution and homogeneity of the scaffold. Overall, the results indicated that when
supplemented with a beneficial surface coating, the constructed microcarriers were
successful at promoting stem cell attachment, growth, and viability without interference
from surface curvature. This research will provide insight for further studies involving
the feasibility of 3D culture on neuronal differentiation, the scale-up advantage of
microcarriers, and clinical therapies.

1. INTRODUCTION

Regenerative medicine is an interdisciplinary field that combines stem cell
therapies and tissue engineering in order to treat disorders through safely restoring and
repairing damaged organs1. Stem cell therapies are anticipated to treat a number of
conditions including cancer, Parkinson’s disease, cardiac failure, neurological disorders,
and Type 1 diabetes2. Even with the continuing advancements with stem cell research,
there is still a set of drawbacks that can hinder the routine use of cell treatments. One
major limitation for stem cell based therapies is the shear number of cells needed for
effective transplantation doses. When considering an effective treatment for Parkinson’s
disease, an individual transplantation should allow for the survival of 105 grafted
dopaminergic neurons3. In a study involving autologous peripheral-blood stem cell
transplantation, an effective dose for neutrophil recovery was between 5 x 106 and 8 x 106
cells per kg of the patient4. Finally, for the clinical use of amniotic fluid stem cells
(AFSCs), around 109 cells are needed for a patient weighing 70 kg5. With two
dimensional (2D) cell culture allowing for only 105 cells/mL, about 10,000 mL of
traditional cell suspension is needed for one transplantation dose5. Therefore, designing a
scalable process for cell expansion independent of traditional cell culture procedures
would be extremely beneficial when producing clinically relevant numbers for cell
transplantation.
1

Typically in research laboratories cell lines are grown on flat surfaces, including
flasks and plates. Although 2D cell culture is widely accepted, it does not fully represent
the natural environment of cells within biological structures such as tissues and organs.
Cells that make up these three-dimensional (3D) structures form a multifaceted
biochemical and mechanical network through cell-to-cell interactions as well as
connections to the extracellular matrix (ECM)6,7. Integrin receptors located on the cell’s
surface allow the cells to link to the ECM, providing not only mechanical support but
also an avenue for communication for important physiological cues involving cell
growth, survival, organization, migration, and differentiation6,8. The geometry of flat
substrates reduces the possibility of cells forming these multidimensional networks, so
there needs to be a bridge between the traditional in vitro cell culture experiments and in
vivo studies.
Growing cells three dimensionally in vitro has its advantages for multiple
applications including cell expansion, drug discovery, and cancer research because it
allows cells to grow in an environment that is closer to in vivo testing9. Using 3D cell
culture systems gives a model prior to in vivo models to overcome the limitations of 2D
cell culture, which can be extremely beneficial since animal studies are typically costly as
well as practically and ethically difficult

10,11

. In addition to the geometrical differences

between 2D and 3D cell culture systems, when considering cell expansion, monolayer
cell culture in petri dishes or flasks is limited by surface area, labor intensive, difficult to
scale-up, and prone to contamination5. 2D static culture systems are suitable for smallscale projects but when considering the enormous quantity of stem cells needed for
effective therapies there needs to be a more efficient way to increase scalability.
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There are various methods of 3D cell culture systems that have been used in
literature, ranging from cell spheroid formation to scaffold-based approaches. These
methods are outlined in Table 1.2, including their advantages and disadvantages.
Originally spontaneous spheroid formation, such as forced-floating, hanging drop, and
spinner flask methods, were used to monitor 3D cell growth and now various scaffold
options are gaining popularity10. Cell spheroids allow for greater cell scalability when
compared

with

monolayer

culture

and

can

mimic

the

stem

cells’

native

microenvironment by cell-cell and cell-ECM connections3. However, because of the cellto-cell contacts within the spheroid, spontaneous differentiation can occur and there can
be cell death in the center of the sphere when the diameter becomes too large3. This will
require dissociation and re-aggregation steps throughout the cell expansion process to
prevent agglomeration, adding additional labor and complexity of this 3D cell culture
system3.
Scaffolds are mainly used for clinical applications and 3D laboratory modeling,
both of which have their own set of requirements. Clinical applications of scaffolds
consist of creating practical implants that not only maintain tissue function but can also
be metabolized into the body without creating an adverse reaction while in vitro models
are used to improve the knowledge of cell biology and tissue physiology by mimicking
the 3D nature of the body12. Important parameters are taken into consideration when
creating scaffolds including porosity, elasticity, biocompatibility, mechanical stability,
support of cell attachment, and diffusion of nutrients and waste in and out of the
scaffold13,14. These aforementioned properties can be adjusted depending on the
technique used during the fabrication process. It is also common to include ECM
3

proteins, such as laminin or collagen, to 3D cell culture systems in order to promote the
cell-to-ECM connections characteristic of naturally occurring three-dimensional
structures. When considering 3D scaffolds for cellular expansion, fibers, hydrogels, and
microcarriers were further explored.
Fibrous scaffolds are manufactured using electrospinning, self-assembly, or phase
separation methods with electrospun scaffolds being the most widely studied technique
for various applications15. Fibers created by electrospinning are done so by forcing a
polymer solution through a syringe that is connected to a voltage source, charging the
solution16. When the electrostatic force overcomes the surface tension of the liquid, a
polymer jet stream is produced from the top of the syringe that then travels and dries in
flight to the ground collector16. Electrospinning has the capacity of adjusting the size of
the nanofibers within the scaffold, ranging from 100-500 nm, which is a major advantage
because the fabricated fibers closely mimic the size of fibrous proteins found in the ECM,
giving cells an environment that is similar to naturally occurring structures16,17. The
increase in surface area-to-volume ratio as well as the microporous nature of fibrous
scaffolds allows for an increase in cell attachment, migration, proliferation, and
differentiation, which are very important when considering stem cell expansion for cell
transplantation applications15,17. However, fibrous scaffolds are limited to their thickness
and small pore size, which can prevent cell migration into the scaffold17. Alterations to
fabrication techniques have been used to overcome these limitations, such as using
ultrasonification in order to increase pore size to 10 microns or larger to allow for a
greater cell infiltration17. Use of multilayer electrospinning has also help improve the
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thickness in order to make the scaffold more 3D in nature as well increase the surface
area for cell attachment17.
Hydrogels are a water-swollen, cross-linked network of polymers that are used for
cell culture because they mimic extracellular matrices, are mechanically similar to most
soft tissues, and can support cell adhesion and growth18. There are number of fabrication
methods that are used to adjust the internal structure of hydrogels, including free radical
polymerization and crosslinking19. Hydrogels can be fabricated using synthetic polymers
or naturally derived materials. The benefit of using synthetic materials is that the physical
properties of the hydrogels can more easily be controlled, such as crosslinking densities
and stiffness, while naturally derived materials, including collagen and fibrin, aid in
biocompatibility and cell integration of the scaffold20. Even though hydrogels are
extremely promising when considering cell culture, they do have their own set of
fallbacks. Similar to fibrous scaffold, hydrogels can have minimal cell penetration within
the scaffold due to the production of small pores during fabrication. Once again this will
not allow cells to grow on the full surface area available. A second limitation to
hydrogels is that it can be challenging when removing the cells embedded within the
scaffold. Detaching cells within the hydrogel can be done by typical mechanical or
enzymatic methods, however it takes great care in order to maintain integrity of
intracellular components as well as produce sufficient cell yields18. It is vital to retrieve
as many cells as possible when using hydrogels for cell expansion so this limitation can
be a major downfall for the proposed application.
Microcarrier cell culture systems (used interchangeably with microspheres and
microbeads) have been used for research purposes since the 1960’s for various
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applications21. Modified microcarriers were used to expand human embryonic cells and
to see the effect of cryopreservation on cells adherent to microcarriers, aggregations of
microcarrier-based systems were designed to produce microtissues, and research was
done on porous microcarriers seeded with stem cells to see the effect on tissue
regeneration22,23,24. Because the growth of adherent cells is limited to area, the geometry
of this scaffold provides a higher surface area-to-volume ratio in comparison to
monolayer cell culture, allowing for increased productions and less physical space
needed25. Microcarriers allow for less cell aggregation and death when compared to cell
spheroid formation due to the fact that cells are grown on a monolayer on the scaffold
surface when using nonporous options, allowing for more nutrient and waste diffusion3.
Even though microspheres are advantageous over monolayer and cell spheroid culture, it
does require more material and equipment cost during the fabrication process. Also, there
are certain fabrication techniques that could prevent the scaffold from being free-floating,
which would negate the benefit of there being an increase in area since the entirety of the
surface would not be available for cell attachment and growth.
This study focuses on fabricating and testing microcarriers of various diameters to
observe if size and curvature have any effect on attachment, metabolic activity, and
differentiation of stem cells. There has been successful studies testing different materials
and coatings of microcarriers but they tend to focus on one size range of fabricated or
commercially bought spheres when conducting cell culture experiments23,26–28. Also,
research has been conducted using microcarriers as avenues for cell expansion for various
cell lines, outlined in Table 1.1. Even though they were able to use coated microcarriers
to promote attachment and proliferation, there were still downfalls that need to be

6

addressed. For the Phillips et al. study, cells were able to attach and proliferate when
grown on commercially available polystyrene beads, however, the final cell densities
were lower than what were previously reported, 5 x 105 cells/ml compared to 1.9-3.5
x106 cells/mL, which is hypothesized to be caused by a difference in size of microcarriers
between the two studies29. Heathman et al. showed that even though the microcarriers
were again successful at promoting a fold- increase in cell quantity, the growth rate
decreased during the second half of the cell culture experiment, showing that the
agglomeration of the microcarriers could limit the effective surface area available for
expansion30. This research was established to attempt to optimize these problems in past
studies and design an adjustable fabrication system to create multi-sized, homogeneous
microcarriers in order to assess the effects of geometry on expanding stem cells for the
purposed of advancing stem cell therapies.
Table 1.1 Various microcarrier-based systems for cell expansion
Microcarrier-Based
System

Cell Line Tested

Expansion (cells/ml)

Trimethylamine-coated Hillex
II polystyrene beads
(diameter=160-200 µm)
Fibronectin-coated, non-porous
plastic microcarriers (diameter
= 160-200 µm)
Collagen-coated, microporous
Cytodex-1 microcarriers under
stirred conditions (diameter
=147-248 µm)
Poly-e-caprolactone
microcarriers coated with
vitronectin or laminin
(diameter = 148-172 µm)

Mouse embryonic stem
cells

5 x 105 after 5 days (3-fold
increase)

29

Human mesenchymal
stem cells

3.01x105 after 6 days (10-fold
increase)

30

Sertoli cells

4.5 x 105 after 6 days (22.7 fold
increase)

31

Human embryonic stem
cells

Vitronectin: 1.7 x 106 after 7
days (5-7 fold increase)

32

Cellulose DE-53 cylindrical
microcarriers coated with
Matrigel under stirred
conditions (diameter = 37 µm)

Human induced
pluripotent stem cells

Laminin: 1.1 x 106 after 7 days
(5-7 fold increase)
6.2 x 106 after 7 days (20-fold
increase)

7

Ref.
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Microcarriers can be either fabricated in-house or bought for research use. Some
commercially available microcarriers are Cytodex (GE Healthcare), Cultispher-G
(Percell), and Hillex II (SoloHill), which are proven to be successful in 3D cell
culture28,34,35. In order to produce microspheres in-house there are a number of methods
that can be used including solvent evaporation, phase separation, and spray drying.
Solvent evaporation is one of the most commonly used methods, which involves
creating an emulsion between an oil component and a water component. This can either
be done as a single emulsion (i.e. oil-in-water, water-in-oil, or oil-in-oil) or a double
emulsion (i.e. water-in-oil-in-water). The material, usually a polymer, forms an oil
solution by dissolving the polymer particles in an organic solvent such as
dichloromethane, acetone, or methylene chloride36. This polymer solution then creates an
emulsion by mixing it with the water component that contains a surfactant, such as poly
(vinyl) alcohol, that stabilizes the emulsion and prevents conglomeration of microcarriers
once they are formed in the aqueous solution36. This emulsion is then mixed continuously
until the solvent has evaporated from the microcarriers and a solid sphere is left37.
Coacervation, or phase separation, is a process where two liquid phases are used
in order to produce microspheres. The first liquid phase is a polymer-rich solution (the
coacervate) that is incorporated with a second more dilute polymer solution, which
decreases the polymer’s solubility38. The key to this technique for microsphere
fabrication is that the two solutions are oppositely charged and immiscible, so when they
are mixed together the separation of phases is induced, creating spheres39. A magnetic
stirring system is used at appropriate speeds in order to prevent the microcarriers from
attaching to one another and forming agglomerations. The formed spheres are hardened
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by pouring the mixture into a non-solvent, counter ion solution before washing and
drying36.
The spray drying technique is used for the fabrication of porous and smaller
microcarriers with a size range of 1-100 microns depending on the specifications of the
nozzle attachment36. The polymer chosen for the microcarriers is dissolved in an organic
solvent and then used with a laboratory spray-dryer. Spray-dryers include a spray nozzle,
an aspirator to provide hot air, a drying chamber, and an area for collecting the dried
particles40. Within the drying chamber, the polymer solution is sprayed out of the nozzle,
producing a fine mist once mixed with the hot gas. Using these commercially available
spray dryers, the solvent within the microspheres is immediately evaporated out, and the
dried microcarriers are then collected by a filter or cyclone36.
For this study, polystyrene has been used to fabricate microcarriers for cell
expansion experiments using a variation of the solvent evaporation emulsion method. A
vibration generator was used in conjunction with a syringe pump in order to create the
oil-in-water emulsion between a polystyrene solution and a poly(vinyl) alcohol solution.
Changing the frequency of the vibration generator that was used in the fabrication setup
was a crucial step when producing different sizes of microcarriers. Traditionally,
polystyrene is used in cell culture vessels because it can easily be sterilized by irradiation,
has great optical clarity, and is easily moldable into various sizes of flasks, plates, and
dishes41. In order for cell attachment proteins to adhere and spread more effectively on
the polystyrene, the surface is modified to change its properties from hydrophobic to
hydrophilic41. Briefly, this done by either corona discharge or gas-plasma, which causes
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oxygen ions to oxidize and graft onto the surface exposed for treatment, leaving a
hydrophilic surface that becomes negatively charged with the addition of media41.
Because polystyrene flasks go through a treatment process to aid in cell
attachment, it was hypothesized that the polystyrene microspheres should also undergo a
treatment process to increase adhesion as well. When certain cell lines are grown in
adherent 2D cell culture, it is required that the surface is treated with a substrate such as
poly-L-ornithine, laminin, fibronectin, or Matrigel to promote attachment, proliferation,
and spreading42. Without this coating the cells will not attach to the polystyrene
cultureware. For this particular study, a previously established peptide solution was used
to promote adherent culture on the polystyrene microcarriers. This peptide covalently
links to the polystyrene surface and leaves a cell attachment domain available. Most cell
lines share a common cell adhesion domain, therefore using this peptide can be
applicable for more a multitude of cell types. This is extremely beneficial because the
microcarrier-based cell culture system established in this study can be generalize for the
expansion of many different cell types.
Neural stem cells (NSCs) were used as an initial model for the microcarrier
system developed in this project for cell expansion. Human NSCs are self-renewing and
multipotential stem cells, meaning they can divide indefinitely into more cells that are
then able to differentiate into all the major cells that make up the adult CNS (neurons,
astrocytes, and oligodendrocytes). An ideal treatment for injured brain tissue is to replace
the damaged cells with healthy neural cells to restore functionality of the CNS43.
However, this comes with it own set of disadvantages including an access to a specific
amount of cells for an effective transplantation dose, immunological rejection, and lack
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of efficacy44. Even though there is still room to grow when it comes to improving
methods for CNS repair, optimally expanding NSCs to increase the number of viable
cells for potential treatments is an important step in the right direction. Using
microcarriers for this purpose is beneficial because the increase in surface area due to the
geometry of spheres allows for more area for cells to grow and later differentiate into
neurons and glial cells.
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Table 1.2: Advantages and disadvantages of various systems for 3D cell culture
Method
Forced-floating45

Hanging drop45

Description
Culture wells are
coated to prevent
attachment, causing
the cells to float and
later form spheroids
by cell-to-cell contact
Small amounts of cell
suspension (~20 µL)
are pipetted onto a
tray, which is then
inverted, forming
hanging drops where
cells form spheroids at
the tip of the drop

Agitation-based
approaches: Spinner
flask bioreactors45

Spinner flasks form
spheroids by
continuously mixing
the cell suspension
with a stirring bar

Agitation-based
approaches:
Rotational culture
systems45

Spheroids are formed
by constantly rotating
the culture system
about a horizontal
axis, preventing the
cells from attaching to
the system walls
Microplates are
separated into units
including inlet/outlet
wells and a culture
chamber (CC). The
cells are immobilized
within the CC,
allowing them to form
spheroids
3D structures, such as
hydrogels and
microcarriers, offer
support for cell
growth by use of
fibers, pores, and an
increase in area

Microfluidic cell
culture platforms45

Scaffolds45
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Advantages
Simple, reproducible,
size is easily
adjustable

Disadvantages
Extra time/work is
required for coatings,
increase in cost by
buying low-adhesion
plates

Simple, reproducible, Cell culture does not
low variability in sizes allow for volumes
larger than 50 µL due
to weight of the drop
overcoming surface
tension. It is also
difficult to change
media without
disturbing the drop
Simple, large yields of Motion causes shear
spheroids, easy
force on the cells
change of media
which adversely
affects physiology,
broad range of
spheroid sizes
Low shear force,
Requires specialized
simple, large
equipment, size of
spheroids yields, easy spheroids varies
change of media

Multi-dimensional
imaging, minimizing
reagent volumes

Retrieval and
characterization of
spheroids can be
difficult

Easily manipulated
with cell adhesion
molecules, growth
factors, or fabrication
techniques

Requirement of
specialized materials
and equipment which
can increase cost,
retrieval of cells from
scaffolds can be
difficult

2. MATERIALS AND METHODS

2.1 Materials
Polystyrene (MW~ 350,000), poly(vinyl alcohol) (average MW~30,000-70,000),
and goat anti-rabbit IgG antibody were purchased from Sigma-Aldrich (St. Louis, MO).
Dichloromethane (DCM) was obtained from Fisher Scientific (Waltham, Massachusetts).
Accutase was purchased from Innovative Cell Technologies (San Diego, CA). Alexa
Fluor® 488 dye and 4’, 6-Diamidino-2-Phenylinole, Dihydrochloride (DAPI) were
purchased from Molecular Probes (Eugene, OR). Recombinant human fibroblast growth
factor-2 (FGF-2) and epidermal growth factor (EGF) were obtained from Peprotech
(Rocky Hill, NJ). Mouse anti-βIII tubulin mAb antibody was purchased from Promega
(Madison, WI). Goat anti-mouse IgG1 antibody was purchased from Invitrogen
(Rockford, IL). Rabbit anti-GFAP antibody was obtained from Abcam (Cambridge, MA).

2.2 Microcarrier Fabrication
A 15% (wt./vol.) polystyrene (PS) solution was produced by dissolving PS
particles into dichloromethane (DCM), an organic solvent not miscible with water. This
was done by using a motorized mixer over several hours to allow for a homogenous
mixture (Scientific Products, Evanston, IL). A 0.5% (wt./vol. in PBS) poly(vinyl) alcohol
(PVA) solution was produced by dissolving PVA in distilled water using a magnetic
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stirrer while heated to 105°C and then filtered to remove any debris or particles that were
not dissolved.
The fabrication set-up is shown in Figure 2.1A. The PS solution was drawn into a
3 mL syringe (BD, Franklin Lakes, NJ) that was topped with a 23 gauge, 1-inch metal
syringe tip (Jensen Global Inc., Santa Barbara, CA). The syringe was securely placed in
the syringe pump (World Precision Instruments, Sarasota, FL) and the pump was placed
vertically on an adjustable platform so that the syringe tip was pointing directly into a
large glass petri dish that was then filled with 200 mL of the 0.5% PVA solution (Figure
2.1A). The syringe was placed underneath the water level to prevent a polymer film
forming on top of the PVA solution (Figure 2.1B). The vibration generator (3B Scientific,
Hamburg, Germany) was placed behind the glass petri dish so that the vibrating arm was
parallel above the dish, intersecting with the syringe tip.

A

B

Figure 2.1: A) Complete microcarrier fabrication system including the vibration
generator, syringe pump, polystyrene solution within the syringe, and poly(vinyl)
alcohol solution within the glass petri dish. B) Close up of the fabrication system.
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The syringe pump began pumping at 150 µL/min. Once the air bubbles were
released from the syringe, large microspheres began to form and drop into the PVA
solution due to an oil-in-water emulsion. A smaller plastic petri dish covered in
aluminum foil was placed in the glass petri dish to catch the first several microspheres
produced before the vibrations began. Once the larger microspheres were formed
regularly, the vibration generator was turned on. The parameters for the vibration
generator were as followed: amplitude of 10V, triangle wave, and the frequency varied
from 18 Hertz to 24 Hertz. When smaller microspheres were wanted, a higher frequency
was used and when larger microspheres were needed a lower frequency was used. After
several microspheres were produced, the smaller plastic petri dish was removed and the
microspheres began to coat the bottom of the glass petri dish until the 3 mL of PS
solution was completely depleted from the syringe, taking about 30 minutes. Each
vibration generator was used for 30 minutes followed by a 3-hour rest to prevent
overheating. Two vibration generators were used to maximize microsphere fabrication.
After the fabrication process, the formed microspheres were allowed to sit in the PVA
solution for 2 to 3 days so that the solvent would fully evaporate and the microspheres
would harden and become opaque.

2.3 Size Separation
After fabrication and hardening, the microspheres underwent a sieving process to
separate them into specific size ranges using different sized test sieves from VWR
(Radnor, PA). The glass petri dishes containing the PVA solution and hardened
microspheres were poured into a 125-micron sieve and those particles that were smaller
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than 125 microns were forced through the sieve by using a plastic squeeze wash bottle
filled with distilled water. The microspheres remaining in the 125-micron sieve were then
transferred to the 212-micron sieve and the samples smaller than 212 microns were
forced through into a beaker using the wash bottle, forming the first size range of 125212 microns. The aforementioned sieving process was continued until the following size
ranges were formed: 125-212 microns, 212-300 microns, 300-355 microns, 355-425
microns, and 425-500 microns. The groups were sieved multiple times to remove any
spheres that did not belong in that range. The microspheres were then stored in 50 mL
conical tubes in PBS until SEM imaging or cell culture experiments.

2.4 SEM Imaging of Microcarriers
Scanning electron microscope (SEM) imaging was used in order determine the
size and 3D topography of the microcarriers. A small amount of microcarriers from each
size group were freeze-dried, or lyophilized, in order to prepare the samples for imaging.
Briefly, the microspheres were frozen in -80°C and then placed in the Labconco
FreeZone® 4.5 Liter Freeze Dry System (Kansas City, MO) overnight. Once fully dried,
the microcarriers were securely added to a mount using double-sided tape and then
covered with a thin layer of gold making the sample conductive, attracting the electrons
within the SEM. The images were obtained using JEOL LV-5610 SEM (Toyko, Japan).

2.5 Human Neural Stem Cell Culture
Human neural stem cells (hNSCs) derived from the ventral midbrain region of the
fetal brain were acquired from Millipore (Billerica, MA). These specific hNSCs are a
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multipotent human neural progenitor stem cell line that has the ability to differentiate into
neurons and glial cells once growth factors are removed from the culture media. hNSCs
are self-renewing and immortalized by retroviral transduction with the v-myc oncogene,
allowing them to successfully go through numerous passages while maintaining their
undifferentiated characteristics. When grown on monolayer plates, it is expected that
100% of the NSCs show expression for nestin before differentiation is induced, which is
the marker for neural stem cells46,47. When considering undifferentiated NSCs, there
should be few or no spontaneous differentiated cells that show expression of beta-III
tubulin, the marker for neurons, and GFAP, the marker for astrocytes46,47. Seven days
after the induction of differentiation, it is normal for there to be a larger percentage of
positive staining for beta-III tubulin and a smaller percentage of the cells showing
expression for GFAP and O1, the surface marker for oligodendrocytes46.
An in-house produced peptide mixture (0.04 mg/ml) was used to coat tissue
culture flasks for up to 4 hours before cell seeding. The hNSCs were maintained in
DMEM/F12 (1:1) medium (Sigma-Aldrich) with added FGF-2 (20 ng/ml) and EGF (20
ng/ml). 2D adherent hNSCs were incubated at 37° C under 5% CO! until they reached

80%-90% confluent.

2.6 Microcarrier Cell Culture
After several serial sievings, each size range produced from the microsphere
fabrication process (125-212 micron, 212-300 micron, 300-355 micron, 355-425 micron,
and 425-500 micron) were separated into two smaller tubes in preparation for surface
coatings. The PBS was removed from each tube and the microspheres were washed
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multiple times with 75% ethanol to sterilize them prior to cell culture experiments. For
the uncoated microcarriers, the samples were washed three times with PBS and then
transferred to suspension 48 well culture plates (Sigma-Aldrich, St. Louis, MO) and
covered with hNSC media. For the peptide-coated microcarriers, the samples were first
coated with 0.01% (wt./vol. in PBS) PVAVS for 10 minutes and then coated with the
same peptide solution used in regular 2D culture flasks for up to 4 hours and then placed
in the suspension 48 well plates. Suspension plates were used in the experiments to
prevent cell attachment to the well surface and promote attachment to the microcarriers.
For both the uncoated and peptide coated microcarriers, the same volume of spheres were
added to each well to coat the bottom of the surface. In addition to the microcarrier trials,
parallel uncoated and peptide-coated 2D samples were run as well. The well plate
configuration is shown in Figure 2.2. The hNSCs grown in flasks were rinsed and then
incubated with Accutase for 5 min at 37°C to detach the cells from the surface and form a
single-cell suspension. After the cell suspension was centrifuged at 220 rcf for 5 minutes,
the supernatant was removed and the cells were resuspended in 1 mL of hNSC media to
prepare for cell counting using the hemocytometer-based trypan blue dye method. Using
this method, it was possible to obtain an accurate count of hNSCs while also obtaining
the different percentages of live and dead cells. Both 2D and 3D sample groups were
seeded with 40,000 cells/well and the media was changed every other day until Day 7.
When necessary, hNSCs grown on microcarriers were dissociated from the surface using
the Accustase protocol previously mentioned.
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Figure 2.2: Schematic of the microcarrier cell culture experiment.

2.7 Metabolic Activity Analysis
Metabolic activity of the hNSCs were analyzed using the alamarBlue® Assay
(Invitrogen). The alamarBlue® Assay is a growth indicator that uses an oxidationreduction reaction that gives both fluorescent and colorimetric information on the
metabolic activity of the samples. In brief, active cells have the ability to continuously
reduce nonfluorescent resaurin, the active ingredient in alamarBlue®, into fluorescent
resorufin. The more metabolically active cells within the sample, the greater the percent
reduction of resazurin and the color of the media will change from blue to bright pink. In
this study, the alamarBlue® Assay was used on Day 7 to analyze the metabolic activity
of the different samples. Media was removed from all wells, the alamarBlue®/media
mixture (1 mL alamarBlue®: 9 mL hNSC media) was added to cover (350 µL), and the
well plate was place in the incubator for 4 hours. A control well was included which was
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an empty well with no cells filled with the AlamarBlue®/media mixture. After 4 hours,
100 µL of the dye was added in triplicate to a 96 well plate from each study group,
including the alamarBlue® control. The 96 well plate was read in the Snergy H1 MultiMode Reader (BioTek Instruments, Inc., Winoski, VT) at two wavelengths: 570 nm and
600 nm. The data was then analyzed using the equation provided below to determine
percent reduced in each study group.
%  Reduced =   

ε!" λ! Aλ! − ε!" λ! Aλ!
  x  100
ε!"# λ! A! λ! − ε!"# λ! A′λ!

With the following parameters:
ε!" = molar  extinction  coefficient  of  alamarBlue®  oxidized  form,
ε!"# = molar  extinction  coefficient  of  alamarBlue®  reduced  form,
A = absorbance  of  test  wells, A! = absorbance  of  negative  control  wells, λ! =
570  nm, λ! = 600  nm, ε!" λ! = 80,586, ε!" λ! = 117,216, ε!"# λ! = 155,677, and
ε!"# λ! = 14,652.

2.8 Immunofluorescence
After the AlamarBlue® Assay analysis, the cells were washed with PBS, fixed
with 4% (wt./vol. in PBS) paraformaldehyde (PFA) and then permeabilized with 0.2%
(vol./vol. in PBS) Triton-X 100 for an additional 30 minutes. For cell attachment studies,
F-actin was stained with Alexa Fluor® 488 dye (5 µL dye: 200 µL PBS) for 2 hours.
After 2 hours, the nuclei were then counterstained with DAPI (1 µL dye: 1000 µL PBS)
for 10 minutes. For differentiation studies, the cells were fixed and permeabilized as
mentioned previously. The cells were then blocked with 10% (vol./vol.) goat serum in
PBS for 30 minutes. The samples were sequentially incubated with the primary
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antibodies for neurons and glial cells overnight at 4° C and then incubated with the
secondary antibodies for 1 hour at room temperature. The nuclei were counterstained
with DAPI for 10 minutes. For neuronal staining, the primary antibody used was mouse
anti-βIII tubulin mAb (G7121) and the secondary antibody used was goat anti-mouse
IgG1 (A-21121, 1:400). For glial staining, the primary antibody used was rabbit antiGFAP (ab7260) and the secondary antibody goat anti-rabbit IgG TRITC (T6778, 1:400).
To characterize the neural stem cells, nestin colocalization was confirmed by using the
primary antibody Mouse Anti-Nestin Antibody (Millipore, MAB5326, 1:100) and the
secondary antibody goat anti-mouse Cy2-conjugated Affinipure, IgG/FCγ1 (Jackson
ImmunoResearch, 15100). The groups were finally washed three times with PBS and
then covered in a 0.1% sodium azide solution in order to preserve the samples.
Microcarriers were imaged over various time periods using an Olympus CKX41 culture
microscope (Melville, NY) to observe cell attachment. Fluorescent images of the stained
undifferentiated and differentiated hNSCs were acquired with an Olympus IX81 confocal
microscope.

2.9 Statistical Analysis
Statistical analysis was performed in MATLAB using one-way analysis of
variance (ANOVA) followed by Tukey’s post-tests. A probability (p) value of < 0.05 was
considered statistically significant. The data is shown as mean ± standard deviation.
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3. RESULTS

3.1 Microcarrier Fabrication
Polystyrene microspheres were fabricated using a variation of the oil-in-water
emulsion technique through a programmable vibration generator in combination with a
syringe pump. The overall goal of the fabrication process was to optimize the size
distribution and homogeneity of the scaffold. The factors controlling the size of the
microcarriers included concentration of the polystyrene solution, thickness of the syringe
tip, rate of the syringe pump, and vibration generator parameters. The most successful
factor when producing various sizes of microcarriers was the parameters of the vibration
generator within the fabrication system, mainly the frequency of the vibrating arm. When
the frequency of the arm was lower (17-19 Hz), the microcarriers formed were larger and
more uniform (Figure 3.1A) and when the frequency was higher (19+Hz) the spheres
were less homogeneous and smaller (Figure 3.1B).

A

B
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Figure 3.1: The diameter of the polystyrene microcarriers decreased and became
less homogeneous when the frequency of the vibrating arm increased. A)
Microcarriers when the vibrating arm was set to 18 Hz. B) Microcarriers produced
when the vibrating arm was set to 22 Hz.
3.2 Characterization of Polystyrene Microcarriers
After fabrication and hardening, the microspheres underwent a multi-step sieving
process in order to separate the samples into specific size spectrums. From this process,
five different sizes ranges were produced which are shown in Table 3.1. A small amount
of microspheres were taken out of the stock batches and freeze-dried for SEM imaging in
order to give a more accurate determination of the size and topography (Figure 3.2). For
each size range, multiple SEM images were taken and 100 microspheres were analyzed.
The images were opened in ImageJ, the scale was set using the legend bar given on the
figure, and the area of the spheres were measured using the circle tool. This area
measurement was then converted to diameter dimensions in Excel, giving the average
diameter data shown in Table 3.1.
Table 3.1: Size characterization of fabricated microcarriers
Size Range (um)

Average Diameter (um)

Size 1 (S1)

125-212

165.41± 21.80

Size 2 (S2)

212-300

256.27  ±  20.46

Size 3 (S3)

300-355

317.33  ±  26.65

Size 4 (S4)

355-425

407.52 ± 26.36

Size 5 (S5)

425-500

470.39 ± 35.42
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Figure 3.2: Microcarriers were produced using a vibration generator in conjunction
with a syringe pump in order to create an oil-in-water emulsion between the
polystyrene solution and the poly(vinyl) alcohol solution and then separated using
various sized sieves. (A) Size 1 (125-212 microns), (B) Size 2 (212-300 microns), (C)
Size 3 (300-355 microns), (D) Size 4 (355-425 microns), (E) Size 5 (425-500 microns).
In the cell culture experiments, roughly the same volume of microcarriers for each
size spectrum was used for each well (~0.12 cm! ), assuming random sphere packing.
The total surface area and volume of one microcarrier was calculated with the formulas
!

𝑉! = ! 𝜋𝑟 ! and 𝑆𝐴! = 4𝜋𝑟 ! . The total amount of spheres per well for each sample size
was then determined by dividing the total volume per well by the volume of one sphere.
This was used to determine the surface area-to-volume ratio for each size spectrum,
shown in Figure 3.3. Size 1 (125-212 microns) had the highest ratio while Size 5 (425500 microns) had the lowest ratio, which was expected because the smaller the diameter
the larger the SA-to-V ratio.
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Figure 3.3: As the diameter of the microcarrier increased, the surface area-tovolume ratio decreased. Size 1 (d=165.41± 21.80 microns) has the highest SA-to-V
ratio (369.09 𝒄𝒎!𝟏 ) while Size 5 (d=470.39 ± 35.42 microns) has the lowest SA-to-V
ratio (128.25 𝒄𝒎!𝟏 ).
3.3 Stem Cell Attachment to Microcarriers
Both optical and confocal imaging were used in order to visualize the ability of
hNSCs to attach and remained attached to the peptide-coated microcarriers while also not
adhering to the surface of the well plate. Immediately after cell seeding, the cells are seen
floating in the culture media (Figure 3.4 A, D, G, J, M) and by Day 2 the cells have
attached to the surface of the microcarriers and formed junctions between the spheres
(Figure 3.4 B, E, H, K, N). The culture experiment was continued for 7 days before the
cells were fixed and then stained with DAPI (nucleus) and phalloidin (actin), further
showing stem cell attachment (Figure 3.4 C, F, I, L, O). By Day 7, the cells within the
wells of the uncoated microcarriers had been washed away by changing of media and
there was minimal attachment to the surface of the spheres (Figure 3.5).

25

A

B

C
C

D

E

F
F

G

H

II

J

K

LL

M

N

OO

26

Figure 3.4: Peptide-coated microcarriers were able to promote human neural stem
cell attachment to the surface of the spheres while in suspension well plates, which
prevented cell attachment to the well surface. Size 1 (A-C), Size 2 (D-F), Size 3 (G-I),
Size 4 (J-L), Size 5 (M-O). Optical images immediately after cell seeding (A, D, G, J,
M) and 48 hours after seeding (B, E, H, K, N). Merged confocal images 7 days after
the start of the experiment, with the nucleus stained with DAPI (blue) and actin
stained with phalloidin (green) (C, F, I, L, O). All scale bars: 200 microns.
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Figure 3.5: Uncoated microspheres at Day 7. There was no significant stem cell
attachment to Size 1 (A), Size 2 (B), Size 3 (C), Size 4 (D), or Size 5 (E). Scale bar:
200 microns.
After confocal imaging, the DAPI images (Figure 3.6 A-F) of the peptide-coated
2D and 3D samples, which respresent the hNSC nuclei, were analyzed in ImageJ to
determine fluorscent intensity followed by cell count. Cell count was normalized by
surface area available with that image, shown in Figure 3.6G. When seeding with the
same density of hNSCs, the 2D and 3D samples resulted in similar cells per mm! , further
showing that microcarriers are able to support cell attachment and growth..
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Figure 3.6: The nuclei of neural stem cells grown on a peptide-coated monolayer (A)
as well as on the varying diameters of peptide-coated microcarriers (B-F) were
stained with DAPI and then analyzed in ImageJ to determine the number of cells
per area. The 2D and 3D samples were statistically similar when comparing
cells/mm2, further showing that the microcarriers aided in the attachment and
spreading of cells when there was a substrate coating. Scale bar: 100 microns.
3.4 Metabolic Activity Analysis
After 7 days in cell culture, the alamarBlue® Assay was performed in order to
assess the cell viability of hNSCs grown in monolayer culture and on the polystyrene
microcarriers. The higher the percent reduction of alamarBlue®, the more metabolically
active cells within that well. For the five size ranges as well as the 2D control, there was
both an uncoated sample group as well as a peptide-coated group. For each pair of
samples, the uncoated group was statistically lower than the peptide-coated group (Figure
3.7), giving evidence that a beneficial coating is necessary to promote cell adhesion for
adherent neural stem cell culture. When comparing all the peptide-coated groups, there
were similarities between the 2D and 3D samples (Figure 3.8), giving further evidence
that the increase in area of the microcarriers promotes cell growth without hindrance
from the surface curvature. However the 2D sample was statistically higher than S3-S5,
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which could be due to loss of microcarriers and therefore loss of hNSCs during media
renewal.
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Figure 3.7: The alamarBlue® Assay was used to assess metabolic activity of the
microcarrier cell culture experiments. The more metabolically active cells within the
sample, the greater the percent reduction of resazurin, the active ingredient within
alamarBlue®. For each microcarrier size as well as the 2D control, the uncoated
sample component was statistically less when it came to percent reduction compared
to its peptide-coated counterpart, showing the benefit of the peptide coating on cell
adhesion.
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Figure 3.8: When comparing the alamarBlue® Assay results for the 2D and 3D
peptide-coated samples, a majority of the groups were statistically similar, showing
that the coated microcarriers were able to promote cell attachment and growth
while also allowing the cells to remain viable and metabolically active. * represents a
significant difference compared to the 2D group and # represents a significant
difference compared to the S1 group.
3.5 Differentiation of Human Neural Stem Cells
Neural stem cells attached to peptide-coated microcarriers were grown in hNSC
media without the addition of growth factors in order to induce neuron and glial cell
differentiation. For this differentiation study, S1 (125-212 microns), S3 (300-355
microns), and S5 (425-500 microns) were used. After 12 days, the multipotency of
hNSCs grown in a three dimensional manner was confirmed by using antibody staining
against specific proteins within neurons and glial cells (Figure 3.9). During this time,
cells not only grew around the curvature of the microcarriers, but also formed junctions
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of cell bodies in between the spheres (Figure 3.9 E, I, M), which was not possible during
monolayer culture (Figure 3.9 A-D).
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Figure 3.9: Peptide-coated microcarriers were able to provide support for hNSC
differentiation to neurons and glial cells after 12 days in differentiation media. 2D
monolayer (A-D), Size 1 (125-212 micron) (E-H). Size 3 (300-355 microns) (I-L). Size
5 (425-500 microns) (M-P). While in differentiation cell culture, neural cells began
forming cellular masses in between microcarriers (E, I, M). Cell nuclei were stained
with DAPI (blue), differentiated neurons were labeled with anti-Beta III tubulin
antibodies (green, column 2), and differentiated glial cells were labeled with antiGFAP antibodies (red, column 3). Column 4 represents the merge of all three dyes.
All scale bars: 100 microns.
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4. DISCUSSION

Pharmacological treatments of neurodegenerative disorders and neural injuries are
available to relieve some symptoms for patients, however, a move intensive method is
needed for long-term repair of the central nervous system48. In order to make positive
strides towards successful therapies for degenerative diseases there needs to be a practical
method to provide a large number of neural stem cells in a timely manner. Microcarriers
are currently being used as a scaffold for adherent cell culture to aid in this expansion
procedure because they provide a larger surface area per unit volume compared to
monolayer culture. When considering cell expansion, a large surface area-to-volume ratio
is advantageous because not only is there more area for cells to attach and proliferate, the
microcarriers also take up less space25. Longer culture times, higher cell density and
effective scalability are also beneficial when using three-dimensional scaffolds in
comparison to normal flask culture.
For this experimental study, multi-sized polystyrene microcarriers were produced
using a vibration generator and solvent evaporation techniques in order to grow and
expand human neural stem cells (hNSCs) in a three dimensional manner. The main
objective of this project was to produce homogenous spheres of varying diameters to
promote cell attachment, proliferation, and differentiation. Different combinations of
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syringe gauge tips, syringe pump rates, and frequency of the vibration generator were
used to determine how the size of the microcarriers would respond. The thicker syringe
tips typically produced larger microcarriers while thinner syringe tips had a tendency to
produce smaller spheres. Also the higher the frequencies (20 Hz and higher), the smaller
and less homogenous the microspheres while larger and more consistent spheres were
produced at lower frequencies (18 Hz and below). When it comes to particle size, the
successful fabrication of microcarriers with varying diameters can be beneficial for
different applications. Smaller spheres sizes have been used for smaller stirred flasks
while larger microcarriers can be used in industrial-sized bioreactors for cell culture
given their higher sedimentation rate due to a higher mass25. To further expand this study,
the microcarrier fabrication system and materials can be modified so that the
microcarriers are free floating within the media without the use of agitation, which can
cause damaging shear force upon the cells. This will allow the entirety of the
microsphere’s area to be available for cell attachment compared to when beads are
coating the bottom of the culture plates. This can be adjusted by changing the
combination of materials used during the fabrication process, such as using a base
solution that is miscible with dichloromethane like acetic acid.
Polystyrene was used in this study because of its optical clarity, biocompatibility,
ease of molding into various structures, and customary use in a laboratory setting. In
order to enhance cell adhesion to the polystyrene, the samples were coated with a peptide
solution. This is advantageous in the long run because the cell attachment domain within
the peptide sequence can be used to adhere various cell lines, making this process open
for more than just NSC culture. Future studies will use different cell lines, such as human
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induced pluripotent stem cells or human mesenchymal stem cells, to compare the
expansion rates. The addition of a peptide coating on both the 2D monolayer samples as
well as all five microsphere sizes proved successful in aiding cell attachment of neural
stem cells 24 hours after cell seeding without the addition of agitation. The cells
remained attached to the microcarriers for up to 7 days before fixing and staining. In
order to amplify the study, staining against nestin can be used in future studies in order to
fully characterize the neural stem cells that have attached the peptide-coated
microcarriers. Typically when NSCs are grown in undifferentiated media in two
dimensions, 100% of the cells stain positive for the nestin marker so it would be
beneficial to compare this quantity to the percentage of cells expressing nestin when
grown on peptide-coated microcarriers46,47. In addition, to verify the viability of the cells
grown on the microcarriers, the LIVE/DEAD Viability Kit should be used, which uses
green fluorescent SYTO 10 to stain live cells and red fluorescent ethidium homodimer-2
to label dead cells. The more viable cells retrieved, the more applicable the microcarriers
will be for stem cell therapies.
Any uncoated samples showed minimal attachment of hNSCs through optical
imaging, further proving the need for a favorable cell adhesion coating for the
polystyrene microcarriers. Cells grown on the peptide-coated microcarriers maintained
their metabolic activity and were comparable to peptide-coated 2D wells. In addition, any
uncoated sample possessed a statistically lower amount of proliferation compared to their
parallel peptide-coated groups. This is a positive outcome because it shows that when
microcarriers are modified with an advantageous coating they are able to promote cell
growth without the curvature of the spheres causing a negative effect. However, when
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comparing certain peptide-coated microcarrier sizes to the 2D samples, there was some
discrepancy between the percent reductions of alamarBlue®, showing that the monolayer
culture had more metabolically active cells compared to the 3D culture when seeding
with the same amount of cells. Even though the numbers were similar, the difference
could be due to loss of microcarriers in cell culture during media renewal or
agglomeration of microcarriers during cell growth. During future studies, this process
will be optimized to prevent microcarrier and cell loss in order to get the most accurate
metabolic activity data.
In order for hNSCs to be used for future clinical studies involving CNS therapies,
they need to maintain their differentiation abilities while undergoing this expansive
process. In this study, hNSCs were able to differentiate into neurons and glial cells
without any hindrance from surface coating or surface curvature when grown on the
fabricated polystyrene microcarriers of varying diameters. Neurons are responsible for
processing and transmitting information within the CNS while glial cells are responsible
for supporting the functions of neurons, so the greater the number of hNSCs that are
expanded through this process and then eventually differentiated in neurons and glial
cells, the more useful this research will be to the end goal of successful neural cell
transplantation49. To further analyze this differentiation experiment, future studies will
include fluorescent-activated cell sorting, or FACS, to determine the percentage of cells
that express neuron and astrocyte markers within the population of differentiated cells
grown on the microcarriers. Typically for NSC culture, a larger portion of the
differentiated cells show expression for beta-III tubulin, the marker for neurons and a
smaller percentage of cells showed expression for GFAP, the marker for astrocytes46. So

35

to prove that microcarriers systems not only support but also have a positive effect on
differentiation, is would expected that the percentage of expression for neurons and
astrocytes would be similar or greater than what is typically seen in NSC cell culture.
Also, a control group will be included where undifferentiated NSCs grown on
microcarriers are stained against beta-III tubulin and GFAP to determine the baseline of
neurons and astrocyte expression. In typical NSC culture, undifferentiated cells showed
close to zero expression for beta-III tubulin and GFAP46,47.
During the differentiation experiments, the cells attached to the surface and
spread around the curvature of the spheres as well as formed cellular masses through cellto-cell interactions, causing the microcarriers to began to agglomerate. This suggests that
microcarriers allow cells to grow in a three dimensional manner as cellular bodies while
also growing as a monolayer on the surface of the spheres, which is an advantage to
traditional flat surfaces because it creates a more in-vivo like environment. However, the
cell masses that begin to form in between microcarriers should be carefully watched
because if the cell density becomes too high the transport of nutrients and waste will
become inefficient and the hNSC may loss their natural abilities to proliferate and later
differentiate.
In order to continue to optimize this system, the polystyrene microcarriers should
be used in larger vessels with varying seeding densities to see how long the scaffold can
support stem cell growth. This study showed that 2D and 3D samples were consistent
when it came to the amount of attachment and metabolically active cells once the 2D
samples became confluent, however, it is expected for the 3D samples to have a higher
cell quantity in the long-term due to the limited surface area of monolayer culture and the
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increase of area in the microcarrier samples. When considering 100% confluency, an
average yield is around 10!   cells/cm! . For a 48 well plate, which was used in this study,
each 2D well is expected to yield about 80,000 cells. Moving forward, the 2D and 3D
samples should be monitored after seeding with 80,000 cells to see the effect of the
increase in area of the microcarriers. In an ideal setting, S1 (average surface area in this
study (SAavg) = 34.8 cm2) will produce a cell yield of 3.5 x 106, S2 (SAavg= 22.6 cm2) will
produce a cell quantity of 2.3 x 106, S3 (SAavg= 19.0 cm2) will produce a cell quantity of
1.9 x 106, S4 (SAavg= 13.6 cm2) will produce a cell quantity of 1.4 x 106, and S5 (SAavg=
11.8 cm2) will produce a cell quantity of 1.2 x 105, shown in Figure 3.10. Therefore,
long-term studies are hypothesized to show the benefit of microcarrier-based systems
over monolayer systems through an increase in cell quantities as well as show the benefit
of using smaller diameter microcarriers due to the increase in surface area available for
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Figure 3.10: Hypothetical cell quantities for 2D and 3D samples once 100%
confluency have been reached.
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5. CONCLUSION

In this study, homogenous polystyrene microcarriers were successfully produced
using an oil-in-water emulsion and vibration generator in order to promote hNSC
attachment, viability, and differentiation. The fabrication technique was optimized to
produce microcarriers of varying diameters. These microcarriers provided a threedimensional environment for cell growth as well as an increase in surface area, both
advantageous when compared to the traditional flat tissue culture plates and dishes. When
supplemented with a beneficial peptide surface coating, cell attachment and proliferation
was significantly amplified without any hindrance due to surface curvature. After 12 days
of being cultured in differentiation media, the hNSCs attached to the microcarriers were
effectively differentiated into neurons and glial cells, which is the ultimate goal for
central nervous system injury treatments by cell transplantation. This research
demonstrates the growing potential of microcarrier-based cell culture systems on future
stem cell therapies through rapid cell expansion.
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